Verrica Pharmaceuticals Inc. — All Filings
513 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-25-071389 | Apr 2, 2025 | Mar 31, 2025 |
| 3 | — | 0001415889-25-009651 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | — | 0001415889-25-009654 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | — | 0001415889-25-008999 | Mar 26, 2025 | Mar 24, 2025 |
| 3 | — | 0001415889-25-008997 | Mar 26, 2025 | Mar 24, 2025 |
| EFFECT | — | 9999999995-25-000779 | Mar 25, 2025 | — |
| CORRESP | — | 0001193125-25-059980 | Mar 21, 2025 | — |
| 4 | — | 0001415889-25-008506 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | — | 0001415889-25-008505 | Mar 18, 2025 | Mar 14, 2025 |
| UPLOAD | — | 0000000000-25-002888 | Mar 17, 2025 | — |
| 10-K | 10-K | 0000950170-25-037172 | Mar 11, 2025 | Dec 31, 2024 |
| S-3 | S-3 | 0001193125-25-052031 | Mar 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-051957 | Mar 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-032003 | Feb 21, 2025 | Feb 18, 2025 |
| SCHEDULE 13G/A | — | 0000950170-25-021211 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001172661-25-001240 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-000897 | Feb 12, 2025 | — |
| 4/A | — | 0001415889-25-003234 | Feb 6, 2025 | Aug 24, 2023 |
| 4/A | — | 0001415889-25-003230 | Feb 6, 2025 | Aug 24, 2023 |
| 4/A | — | 0001415889-25-003231 | Feb 6, 2025 | Aug 24, 2023 |
| 4/A | — | 0001415889-25-003233 | Feb 6, 2025 | Aug 24, 2023 |
| 4/A | — | 0001415889-25-003232 | Feb 6, 2025 | Aug 24, 2023 |
| 8-K | 8-K | 0001193125-25-017264 | Jan 30, 2025 | Jan 24, 2025 |
| SC 13G/A | SC 13G/A | 0001193125-24-273581 | Dec 9, 2024 | — |
| 8-K | 8-K | 0001193125-24-273406 | Dec 9, 2024 | Dec 4, 2024 |
| S-8 | S-8 | 0001193125-24-273484 | Dec 9, 2024 | — |
| 3 | — | 0001415889-24-028671 | Dec 9, 2024 | — |
| 4 | — | 0001415889-24-028674 | Dec 9, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-24-123093 | Nov 26, 2024 | — |
| 4 | — | 0001415889-24-027710 | Nov 26, 2024 | Nov 22, 2024 |
| 4 | — | 0001415889-24-027711 | Nov 26, 2024 | Nov 22, 2024 |
| 4 | — | 0001415889-24-027709 | Nov 26, 2024 | Nov 22, 2024 |
| 424B5 | 424B5 | 0001193125-24-263473 | Nov 21, 2024 | — |
| 8-K | 8-K | 0001193125-24-263477 | Nov 21, 2024 | Nov 20, 2024 |
| 8-K | 8-K | 0001193125-24-262615 | Nov 20, 2024 | — |
| 424B5 | 424B5 | 0001193125-24-262611 | Nov 20, 2024 | — |
| SC 13G/A | VERRICA PHARMACEUTICALS INC. | 0000902664-24-006523 | Nov 14, 2024 | — |
| 4 | — | 0001415889-24-026286 | Nov 6, 2024 | — |
| S-8 | S-8 | 0001193125-24-252195 | Nov 6, 2024 | — |
| 3 | — | 0001415889-24-026288 | Nov 6, 2024 | Nov 5, 2024 |
| 4 | — | 0001415889-24-026290 | Nov 6, 2024 | — |
| 3 | — | 0001415889-24-026284 | Nov 6, 2024 | Nov 5, 2024 |
| 10-Q | 10-Q | 0000950170-24-120982 | Nov 5, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001193125-24-250638 | Nov 4, 2024 | Nov 1, 2024 |
| 4 | — | 0001415889-24-025026 | Oct 11, 2024 | Oct 9, 2024 |
| 8-K | 8-K | 0001193125-24-234391 | Oct 8, 2024 | Oct 2, 2024 |
| 8-K | 8-K | 0001193125-24-230240 | Oct 1, 2024 | — |
| 8-K | 8-K | 0001193125-24-227975 | Sep 27, 2024 | Sep 23, 2024 |
| 4 | — | 0001415889-24-023835 | Sep 23, 2024 | Sep 19, 2024 |
| 8-K | 8-K | 0001193125-24-215180 | Sep 6, 2024 | Aug 30, 2024 |